Inhibition of S6 Kinase activity for the treatment of insulin resistance
2005
Abstract
This invention provides screening methods for agents effective in treating insulin resistance through specific inhibition of S6 kinase 1 activity. Also provided are methods of treating insulin resistance by administering an effective amount of an inhibitor specific for S6 kinase 1
Details
Title
Inhibition of S6 Kinase activity for the treatment of insulin resistance
Author(s)
Auwerx, J. ; Frigerio, F. ; Fumagalli, S. ; Kozma, S. ; Picard, F. ; Sticker-Jantscheff, M. ; Thomas, G. ; Um, S.H. ; Watanabe, M.
Date
2005
Note
Applicant(s): Novartis Forschungsstiftung [CH]
Alternative title(s) : (de) Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz (fr) Inhibition de l'activite de la kinase s6 pour traiter la resistance a l'insuline (en) Inhibition of s6 kinase activity for the treatment of insulin resistance
Alternative title(s) : (de) Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz (fr) Inhibition de l'activite de la kinase s6 pour traiter la resistance a l'insuline (en) Inhibition of s6 kinase activity for the treatment of insulin resistance
Other identifier(s)
EPO Family ID: 34216100
Patent number(s)
ES2331006 (T3)
DE602004022423 (D1)
AT438859 (T)
EP1658504 (B1)
US2007191259 (A1)
JP2007503203 (A)
EP1658504 (A1)
WO2005019829 (A1)
DE602004022423 (D1)
AT438859 (T)
EP1658504 (B1)
US2007191259 (A1)
JP2007503203 (A)
EP1658504 (A1)
WO2005019829 (A1)
Laboratories
NCEM
Record Appears in
Scientific production and competences > SV - School of Life Sciences > IBI-SV - Interfaculty Institute of Bioengineering > NCEM - Nestlé Chair in Energy Metabolism
Work outside EPFL
Patents
Work outside EPFL
Patents
Record creation date
2009-04-20